Published in Infect Immun on May 01, 1982
Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization. J Exp Med (1992) 3.30
Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies. J Virol (1983) 2.24
Natural variation of poliovirus neutralization epitopes. Infect Immun (1983) 2.01
Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment. J Virol (1984) 1.75
Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis. J Virol (2011) 0.91
A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. Am J Public Health (1989) 0.89
Structural analysis of hepatitis B surface antigen by monoclonal antibodies. J Clin Invest (1985) 0.88
Intertypic cross-reactions of nonneutralizing, monoclonal poliovirus antibodies. J Virol (1984) 0.80
A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol (1979) 16.56
Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology (1981) 2.64
The use of a modified Wecker technique for the serodifferentiation of type 1 polioviruses related and unrelated to Sabin's vaccine strain. I. Standardization and evaluation of the test. Am J Hyg (1962) 2.21
Production of monoclonal antibodies against nucleocapsid proteins of herpes simplex virus types 1 and 2. J Virol (1979) 1.97
Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein. J Gen Virol (1980) 1.96
Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus. J Virol (1980) 1.91
Complement-fixing antigens produced by varicella-zoster virus in tissue culture. Appl Microbiol (1973) 1.01
Epidemiological implications of the isolations and intratypic serodifferentiation of poliovirus strains in the Netherlands. Dev Biol Stand (1981) 0.92
Geographic distribution of wild poliovirus type 1 genotypes. Virology (1987) 4.03
Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV). J Immunol Methods (1985) 3.91
Genetic co-regulation of galactose and melibiose utilization in Saccharomyces. J Bacteriol (1976) 2.92
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology (1981) 2.64
Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors. N Engl J Med (1985) 2.62
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Multiple genetic changes can occur in the oral poliovaccines upon replication in humans. J Gen Virol (1981) 2.54
Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res (1991) 2.35
Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res (1992) 2.33
Protein processing map of poliovirus. J Virol (1984) 2.33
Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA (1987) 2.28
Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J Clin Microbiol (1996) 2.23
Primary Epstein-Barr-virus infections in acute neurologic diseases. N Engl J Med (1975) 2.02
Lymphadenopathy associated virus infection of a blood donor--recipient pair with acquired immunodeficiency syndrome. Science (1984) 1.97
Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus. J Virol (1980) 1.91
Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol (1995) 1.83
Possible female-to-female transmission of human immunodeficiency virus. Ann Intern Med (1986) 1.82
Picornaviral VPg sequences are contained in the replicase precursor. J Virol (1980) 1.77
Condoms as physical and chemical barriers against human immunodeficiency virus. JAMA (1988) 1.74
The natural history of infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III. Ann Intern Med (1985) 1.71
Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol (2000) 1.71
Infection of chimpanzees with lymphadenopathy-associated virus. Lancet (1984) 1.67
Transfusion-associated acquired immunodeficiency syndrome in the United States. JAMA (1985) 1.61
Micromethod for assaying reverse transcriptase of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. J Clin Microbiol (1987) 1.61
Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J Virol (2000) 1.54
Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med (1981) 1.52
Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. J Clin Microbiol (2000) 1.50
Detection by indirect immunofluorescence of Fc receptors in cells acutely infected with Herpes simplex virus. Int Arch Allergy Appl Immunol (1977) 1.46
Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III. JAMA (1986) 1.33
Dried-plasma transport using a novel matrix and collection system for human immunodeficiency virus and hepatitis C virus virologic testing. J Clin Microbiol (2009) 1.32
Risk of human immunodeficiency virus infection from blood donors who later developed the acquired immunodeficiency syndrome. Ann Intern Med (1987) 1.29
Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro. J Virol (1994) 1.25
Insights into HIV chemotherapy. AIDS Res Hum Retroviruses (1992) 1.25
Comparison of diagnostic tests for infectious mononucleosis. J Am Coll Health Assoc (1971) 1.24
Resolution of the pathways of poliovirus type 1 transmission during an outbreak. J Clin Microbiol (2000) 1.23
Molecular epidemiology of wild poliovirus type 1 in Europe, the Middle East, and the Indian subcontinent. J Infect Dis (1995) 1.18
Bell's palsy and infectious mononucleosis. Lancet (1973) 1.17
National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 2. Laboratory results. Ann Intern Med (1983) 1.16
A continuing surveillance of enterovirus infection in healthy children in six United States cities. II. Surveillance enterovirus isolates 1960-1963 and comparison with enterovirus isolates from cases of acute central nervous system disease. Am J Epidemiol (1966) 1.13
Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men. Ann Intern Med (1985) 1.13
Detection of monoclonal influenza antibodies synthesized in culture by hybridoma cells with a solid-phase indirect immunofluorometric assay. J Virol Methods (1980) 1.09
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol (1994) 1.09
Use of DEAE dextran in agar overlays to enhance size of ECHO virus plaques. Public Health Rep (1966) 1.08
Viral antibodies in patients with primary myocardial disease. Am J Cardiol (1968) 1.06
Mononucleosis-associated subacute sclerosing panencephalitis. Lancet (1975) 1.05
Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls. J Infect Dis (1973) 1.05
Oligonucleotide probes for the specific detection of the wild poliovirus types 1 and 3 endemic to Brazil. Intervirology (1991) 1.04
Hand, foot, and mouth disease (Coxsackievirus A16) in Atlanta. Am J Dis Child (1967) 1.04
Epstein-Barr virus and Guillain-Barré syndrome. Lancet (1972) 1.03
Radioimmunoassay for detection of antibodies to Epstein-Barr virus in human infectious mononucleosis serum specimens. J Clin Microbiol (1975) 1.03
Molecular epidemiology of polioviruses. Rev Infect Dis (1984) 1.01
Viral isolation studies of inclusion positive biopsy from human connective tissue diseases. Arthritis Rheum (1970) 1.00
Coupled mutations in the 5'-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications. Virus Res (1991) 0.99
Oligonucleotide fingerprint analysis of enterovirus 70 isolates from the 1980 to 1981 pandemic of acute hemorrhagic conjunctivitis: evidence for a close genetic relationship among Asian and American strains. Infect Immun (1983) 0.99
Poliomyelitis in the USA: virtual elimination of disease caused by wild virus. Lancet (1984) 0.99
Generalized eruption in a child with eczema due to coxsackievirus A16. Arch Dermatol (1968) 0.98
Evaluation of two types of infectious mononucleosis antigen slides by the indirect fluorescent-antibody technique. Appl Microbiol (1973) 0.98
The epidemiology of infection with the human herpesviruses in Navajo children. Am J Epidemiol (1988) 0.96
Distribution of wild type 1 poliovirus genotypes in China. J Infect Dis (1993) 0.96
Molecular characterization of a wild poliovirus type 3 epidemic in The Netherlands (1992 and 1993). J Clin Microbiol (1995) 0.94
Geographical genotypes (geotypes) of poliovirus case isolates from the former Soviet Union: relatedness to other known poliovirus genotypes. J Gen Virol (1995) 0.93
Natural variants of the Sabin type 1 vaccine strain of poliovirus and correlation with a poliovirus neutralization site. Virology (1985) 0.91
Preparation of glutamate dehydrogenase from Micrococcus aerogenes. Biochem Biophys Res Commun (1970) 0.90
Biologic properties of human herpesvirus 7 strain SB. Virus Res (1997) 0.89
A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. Am J Public Health (1989) 0.89
Lack of correlation between human herpesvirus-6 infection and the course of human immunodeficiency virus infection. J Infect Dis (1990) 0.89
Analysis and characterization of herpes simplex virus after its persistence in a lymphoblastoid cell line for 15 months. Infect Immun (1980) 0.88
T-cytotoxic/suppressor cell phenotypes in a group of asymptomatic homosexual men with and without exposure to HTLV-III/LAV. Clin Immunol Immunopathol (1986) 0.87
Regions of poliovirus protein VP1 produced in Escherichia coli induce neutralizing antibodies. J Virol (1987) 0.87
Genetic heterogeneity of the attachment glycoprotein G among group A respiratory syncytial viruses. Virus Res (1994) 0.87
The safety of the hepatitis B vaccine. Inactivation of the AIDS virus during routine vaccine manufacture. JAMA (1986) 0.86
The 2010 outbreak of poliomyelitis in Tajikistan: epidemiology and lessons learnt. Euro Surveill (2014) 0.86
Kawasaki-like disease in a young adult. Association with primary Epstein-Barr virus infection. JAMA (1979) 0.84
Eradication of wild poliovirus from the Americas: wild poliovirus surveillance--laboratory issues. J Infect Dis (1997) 0.84
Molecular detection of an importation of type 3 wild poliovirus into Canada from The Netherlands in 1993. Appl Environ Microbiol (1997) 0.83
Outbreak of poliomyelitis in Gizan, Saudi Arabia: cocirculation of wild type 1 polioviruses from three separate origins. J Infect Dis (1997) 0.83
Persistent infection of a human lymphoblastoid cell line with equine herpesvirus 1. Infect Immun (1979) 0.82
Epstein-Barr virus and transverse myelitis. Lancet (1973) 0.82
Acute Chlamydia trachomatis respiratory infection in childhood. Serologic evidence. Am J Dis Child (1986) 0.82
Application of a solid-phase immunofluorometric assay to the selection of monoclonal antibody specific for the adenovirus group-reactive hexon antigen. Arch Virol (1984) 0.81
Increased antibody to herpes simplex virus in patients with nasopharyngeal cancer. J Infect Dis (1972) 0.80
Herpes simplex virus type 2 and cancer of the prostate. J Urol (1976) 0.80
Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus. J Infect Dis (1975) 0.80
Malaria antibody levels in patients with Burkitt's lymphoma. Am J Trop Med Hyg (1974) 0.80
HTLV-III viremia in homosexual men with generalized lymphadenopathy. N Engl J Med (1985) 0.80
Application of the polymerase chain reaction (PCR) to poliomyelitis surveillance through the analyses of sewage samples. World J Microbiol Biotechnol (1993) 0.78
HTLV-III/LAV infection in hemodialysis patients. JAMA (1986) 0.78
Antibody against the human immunodeficiency virus in commercial intravenous gammaglobulin preparations. Ann Intern Med (1986) 0.78
Detection of two human T cell leukemia/lymphotropic viruses in cultured lymphocytes of a hemophiliac with acquired immunodeficiency syndrome. J Infect Dis (1985) 0.77
HBs-Ag-negative hepatitis in a hemodialysis unit: relation to Epstein-Barr virus. N Engl J Med (1975) 0.77
Demonstration of human immunodeficiency virus by colorimetric in situ hybridization: a rapid technique for formalin-fixed paraffin-embedded material. Mod Pathol (1989) 0.76
Isolation of human immune deficiency virus from African AIDS patients and from persons without AIDS or IgG antibody to human immune deficiency virus. Am J Trop Med Hyg (1987) 0.76
Reemergence of an epidemic coxsackievirus B5 genotype. J Infect Dis (1987) 0.75
The cause of acquired immunodeficiency syndrome--is it known? Prog Clin Biol Res (1985) 0.75
Intratypic differentiation & partial nucleotide sequencing of poliovirus isolates of northern India. Indian J Med Res (2000) 0.75
Nucleotide sequences of the VP1 capsid proteins of wild poliovirus types 1 and 3 from epidemic areas of Brazil. Braz J Med Biol Res (1990) 0.75
Poliomyelitis in Angola: current status and implications for poliovirus eradication in Southern Africa. J Infect Dis (1997) 0.75
Strain characterization studies of poliovirus type I isolates from poliomyelitis cases in the United States in 1979. Dev Biol Stand (1981) 0.75